Risk Severity Model for Pediatric Autosomal Dominant Polycystic Kidney Disease Using 3D Ultrasound Volumetry

1Department of Radiology, University Hospitals Leuven, Leuven, Belgium

2PKD Research Group, Department of Cellular and Molecular Medicine, KU Leuven, Leuven, Belgium

3Department of Nephrology, Dialysis and Renal Transplantation, University Hospitals of Leuven, Leuven, Belgium

4Department of Pediatrics, ULiège Academic Hospital, Liège, Belgium

5Department of Pediatric Nephrology, University Hospitals Leuven, Leuven, Belgium

6Department of Nephrology and Arterial Hypertension, Universitair Ziekenhuis Brussel (UZ Brussel), Vrije Universiteit Brussel, Brussels, Belgium

7Laboratory of Ion Channel Research, Department of Cellular and Molecular Medicine, VIB Center for Brain and Disease Research, KU Leuven, Leuven, Belgium

8Department of Internal Medicine, Division of Nephrology and Hypertension, Mayo Clinic, Rochester, Minnesota

Correspondence: Dr. Djalila Mekahli, PKD Research Group, Department of Cellular and Molecular Medicine, KU Leuven, Leuven, Belgium, and Department of Pediatric Nephrology, University Hospitals Leuven, Herestraat 49, Leuven B-3000, Belgium. Email: [email protected]

*Members of CRISP Consortium: A Yu (Kansas Medical Center), AB Chapman (University of Chicago), FF Rahbari Oskoui (Emory University), VE Torres, FT Chebib (Mayo Clinic), DP Landsittel (University of Pittsburgh), WM Bennett (Legacy Health, Portland), M Mrug (University of Alabama, Birmingham), and KT Bae (University of Hong Kong).

留言 (0)

沒有登入
gif